Global Monoclonal Antibodies Market Forecasts 2021-2030, By Source, Indication and End User - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Monoclonal Antibodies Market by Source, Indication and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.

The global monoclonal antibodies market was valued at $146,642 million in 2020, and is projected to reach $390,582 million by 2030, registering a CAGR of 10.2% from 2021 to 2030.

The growth of the monoclonal antibodies market is driven by a rise in the prevalence of cancer and other chronic diseases, increase in government funding for cancer research and technology developments, and a surge in adoption of humanized monoclonal antibodies (mAbs) in the treatment of several diseases including inflammatory, cancer, and autoimmune diseases. In addition, a rise in demand for personalized medicines, increase in development of therapeutic monoclonal antibodies, and surge in research collaborations for the development of robust drugs pipeline drives the growth of the market.

Moreover, increasing government support in infection control & management, a rise in patient awareness regarding applications of murine monoclonal antibodies therapy, increasing number of clinical trials, and the introduction of low-priced biosimilar monoclonal antibodies are the other factors that boost the growth of the market. However, poor demand in underdeveloped countries is expected to restrain the growth of the monoclonal antibodies market. Conversely, growth avenues in emerging markets are expected to offer lucrative opportunities during the forecast period.

The monoclonal antibodies market is segmented into source, indication, end user, and region. On the basis of source, the market is categorized into murine, chimeric, humanized, and human. By indication, the market is divided into cancer, autoimmune diseases, inflammatory diseases, infectious diseases, and others. The cancer segment is further classified into breast cancer, colorectal cancer, lung cancer, ovarian cancer, and others. By end user, the market is fragmented into hospitals, research institutes, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA

Key benefits for stakeholders

• The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
• A comprehensive analysis of four regions is provided to determine the existing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

   

Key Topics Covered:

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET LANDSCAPE

3.1. Market definition and scope

3.2. Key findings

3.3. Porter's five force analysis

3.4. Top player positioning, 2020

3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Rise in prevalence of various cancer types

3.5.1.2. Increase in demand of cost-efficient biosimilar monoclonal antibodies

3.5.1.3. Upsurge in likelihood of epidemic or pandemic outbreaks

3.5.2. Restraint

3.5.2.1. Poor demand in underdeveloped countries

3.5.3. Opportunities

3.5.3.1. Growth opportunities in emerging markets

3.5.4. Impact analysis

3.6. Covid-19 Impact analysis on monoclonal antibodies market

CHAPTER 4: MONOCLONAL ANTIBODIES MARKET, BY SOURCE

CHAPTER 5: MONOCLONAL ANTIBODIES MARKET, BY INDICATION

CHAPTER 6: MONOCLONAL ANTIBODIES MARKET, BY END USER

CHAPTER 7: MONOCLONAL ANTIBODIES MARKET, BY REGION

CHAPTER 8: COMPANY PROFILES

• Abbott Laboratories
• Amgen Inc.
• AstraZeneca plc
• Bayer AG
• Eli Lilly
• GlaxoSmithKline Plc
• Johnson & Johnson
• Merck & Co. Inc.
• Novartis
• Pfizer

For more information about this report visit https://www.researchandmarkets.com/r/e5rwqd

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.